A Phase II Trial of LDK378 in ROS1 and /or ALK Over-expressed Advanced Intrahepatic or Hilar Cholangiocarcinoma

NCT02374489 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
9
Enrollment
OTHER
Sponsor class

Stopped ROS1 in IHC and gene rearrangement result can not match。No tumor response。

Conditions

Interventions

Sponsor

National Health Research Institutes, Taiwan

Collaborators